Welcome Message

Welcome to the 19th World Congress on Drug Formulation & Drug Delivery, WCDFDD-2023 which will be held in Bangkok, Thailand, on November 27–28, 2023. Drug Delivery-2023 provides a brand-new forum for discussing and exchanging innovative drug formulation and drug delivery system concepts. Meet the world's leading experts and lecturers at our sessions as they discuss the most recent developments in drug discovery and discuss new developments in drug formulation and drug delivery. This will provide a fantastic venue for academics, experts, scientists, and students to present their work and be recognized by the most influential people.

I invite you all for this Drug Formulation & Drug Delivery 2023 to make a new Innovations and technologies

About Conference

It gives us great pleasure and honor to invite you to speak at the "19th World Congress on Drug Formulation & Drug Delivery" which will take place in Bangkok, Thailand, on November 27-28, 2023. Its main topic is “Future Prospective and New Era Technologies in Pharmaceutics and Drug Delivery"

The 19th World Congress on Drug Formulation & Drug Delivery WCDFDD-2023 brings a chance to gift and discuss all the inventions in Drug Formulation and Drug delivery Sessions. This congress permits foremost educational scientists, researchers and industrialists from universally the planet to interchange and share their experiences, new innovations, practical challenges, and advanced instrumentation and analysis results. Drug Discovery has a wider set of speakers, and a broader collection of programs geared toward each scientists and industrialists. This congress offers an important prospect to express regarding the foremost recent advancements latest developments among the sector.

Scientific Sessions

Track 1: Pharmacokinetics & Pharmacodynamics

Pharmacokinetics vs. Pharmacodynamics. The main difference between pharmacokinetics and pharmacodynamics is that pharmacokinetics (PK) is defined as the movement of medicines through the body, whereas pharmacodynamics (PD) is defined as the body's natural response to medicines. In vivo safety pharmacology studies should be designed to precisely define the cure- response relationship of the adverse effect observed. Pharmacodynamics (PD) is the study of the physiologic and biochemical goods of medicines (especially pharmaceutical medicines) and to discover how the medicine affects the organism.

Track 2: Clinical Trials & Bio therapeutics

Utmost biomedical exploration involves clinical trials, which are phased studies using human levies, designed to answer safety and efficacy questions about biologics, devices, medicinal, new curatives or new ways of using known treatments. bio therapeutics are “ antibody- medicine cell remedy products where the active substance is extracted or produced from a natural source ” Bio therapeutic products include proteins and hormones, monoclonal antibodies, cytokines, antibodies.

Track 3: Novel Drug Delivery System

A new medicine delivery system( NDDS) is an expression substantially associated with the expression of new pharmaceutical forms which have optimized characteristics similar as lower flyspeck size, advanced permeability parameters, and picky point targeting. The development of several types of NDDS in the last many decades includes (Micro particles, Nanoparticles, Liposomes, Noisome, Transdermal medicine delivery, and Microencapsulation) with the motive of delivering medicines to targeted towel to cure certain conditions.

Track 4: Medicinal Chemistry & Drug Discover Advancements

Medicinal chemistry refers to the discovery, design, and product of new drugs. Medicinal chemistry combines natural understanding of the crucial proteins and processes contributing to complaint. Organic chemistry knowledge to design, develop and synthesize the composites that alter the complaint- causing motes. Several ways like RNA and nanotechnology hindrance are being employed for drug discovery WCDFDD-2023, in turn generating openings for the manufacturers of medicine discovery technology in new parts.

Track 5: Drug Product Manufacturing

Pharmaceutical manufacturing is the process of artificial- scale conflation of pharmaceutical medicines as part of the pharmaceutical assiduity. The process of medicine manufacturing can be broken down into a series of unit operations, similar as milling, granulation, coating, tablet pressing, and others. A pharmaceutical company, or medicine company, is a marketable business certified to exploration, develop, request and/ or distribute medicines, utmost generally in the environment of healthcare.

Track 6: Chemical and Pharmaceutical Engineering

Chemical Engineering. Pharmaceutical engineering can be considered a branch of chemical engineering. It's asub-specialisation that specifically focuses on the product of drugs WCDFDD-2023 and other pharmaceutical products. Pharmaceutical requires the introductory and abecedarian expression and analysis while chemical engineering determines cost-effective process grounded on a feasibility study. Chemical Engineering is used for the mass product of pharmaceutical products or lifesaving products.

Track 7: Business Opportunities in Drug Delivery

Some of the most profitable healthcare business ideas are Medical business services, online drugstore, healthcare record operation, transcribing services, mobile apps, and much further. About 92 percent of tradition medicines in the United States are distributed through wholesalers, with three Amerisource Bergen, Cardinal Health, and McKesson Corporation counting for further than 90 percent of noncommercial medicine distribution in the United States.

Track 8: Drug Design & Development

Drug design is the inventive process of chancing new specifics grounded on the knowledge of a natural target. In the most introductory sense, medicine design involves the design of motes that are reciprocal in shape and charge to the molecular target with which they interact and bind. Medicine design constantly but not inescapably relies on computer modeling ways. This type of modeling is occasionally appertained to as computer- backed medicine design. Eventually, medicine design that relies on the knowledge of the three- dimensional structure of the bimolecular target is known as structure- grounded medicine design.

Track 9: Computer Aided Drug Design (CADD)

Computer- backed Drug Design (CADD) surfaced as an effective means of relating implicit lead                                                               composites and for abetting the developments of possible medicines for a wide range of conditions. Moment, a number of computational approaches are being used to identify implicit lead motes from huge emulsion libraries. Computer- backed medicine design (CADD) comprises a broad range of theoretical and computational approaches that are part of ultramodern medicine discovery. CADD styles have made crucial benefactions to the development of medicines that are in clinical use or in clinical trials.

Track 10:  Biomarkers in Drug Design

A biomarker used to descry or confirm presence of a complaint or condition of interest or to identify individualities with a subtype of the complaint. Individual biomarkers are decreasingly common in medicine development and used for patient segmentation in perfection drug strategies. Biomarkers enable the characterization of patient populations and quantitation of the extent to which new medicines reach intended targets, alter proposed pathophysiological  mechanisms and achieve clinical issues.

Track 11:  Pre-Formulation & Formulation Aspects

Formulation studies aim to develop a drug medication which is both stable, safety and respectable to the case. Pre-formulation studies are an essential element of medicine development process, and it provides the scientific base for expression development. Preformulation is the stage of development during which the physicochemical parcels of the medicine substance are characterized and established. Knowledge of the applicable physiochemical and biopharmaceutical parcels determines the applicable expression and delivery system for Pre-Clinical and Phase 1 studies.

Track 12: Innovative Drug Discovery and Nanotechnology

Several ways like RNA and nanotechnology hindrance are being employed for medicine discovery, in turn generating openings for the manufacturers of medicine discovery technology in new parts. Nanoparticles can be modified in several ways to protract rotation, enhance medicine localization, increase medicine efficacy and potentially drop the development of multidrug resistance through the use of nanotechnologies.

Track 13: Pharmaceutical Regulatory Affairs

Pharmaceutical Regulatory Affairs, or Pharma Regulatory Affairs, refers to the professionals who maintain regulations from within the assiduity. The pharmaceutical assiduity is the most regulated of all diligence. Regulatory affairs professionals are crucial, but maybe overlooked, players in medicine development. The department of Regulatory Affairs is established to cover public health, by covering and controlling the safety and efficacy of medicines within several disciplines including medicinal, veterinary medicines, agrochemicals, cosmetics, medical devices, fungicides, and reciprocal medicines. The civil controllers are The Office of the Comptroller of the Currency (OCC) The Federal Reserve System.

Track 14: Pharmaceutical Manufacturing

The Pharmaceutical Manufacturing Technology (PMT) program is a specialized chemical technology program designed to meet the needs of the pharmaceutical and related industries the pharmaceutical industry includes the manufacture, extraction, processing, purification, and packaging of chemical materials to be used as medications for humans or animals. Pharmaceutical careers are highly lucrative. When you establish your position in this industry, you open your doors to countless opportunities for growth and learning. People working in Pharma get numerous benefits, as well as exceptional salaries. Job satisfaction and sense of achievement are also high.

Track 15: NMR and Analysis of Small Organic Molecules

Nuclear magnetic resonance (NMR) is an important technique for elucidating unknown organic molecules. But its sensitivity is limited and many elements lack an isotope observable by NMR. Thus, a complete structure elucidation relies on several spectroscopic techniques and is normally performed by experienced spectroscopes. Because almost all stable elements in the periodic table have at least one isotope with a non-zero magnetic moment, NMR can be used to study a wide variety of inorganic substances. NMR spectroscopy is mainly used as an analytical tool in organic chemistry and biochemistry. It can determine the composition and structure of any organic molecule that has a spin value. The technique can also help identify chemical and physical properties such as conformational change, phase changes, and solubility.

Market Audiencce

The Drug delivery WCDFDD request is prognosticated to reach approx. USD billion by 2023 from USD billion in 2018, at an Emulsion Annual Growth Rate of6.4 during the prognosticated period. The Growth in the request of medicine delivery is substantially directed by the increase in the frequency of habitual conditions, growth in technological advancements and the biologics request, and new product launches. On the other hand, the threat of needle stick injuries (numerous Infections) and the rise in pricing pressure are anticipated to claim request growth in the forthcoming times. In addition, the cases’ heartiness has progressed vastly with ever- perfecting robotization, and possibilities and capabilities of massive improvements in this field have pushed the medicine delivery assiduity to a new height, and in having an astonishing growth in Drug delivery systems for hormones and cardiology agents. The global request for advanced medicine delivery systems is prognosticated to quantum to a value of$196.4 billion by 2025 at a7.2 CAGR

Drug delivery WCDFDD mention to technologies, formulations, approaches, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its required therapeutic effect. The market is currently estimated to be worth USD 18.5 billion for the year 2018 and is expected to reach USD 51.7 billion by the end of 2025. The CAGR during this period of the forecast is 22.78%. Currently, North America dominates the global market owing to the fact that there is greater awareness and increase per capita income. The USA is the biggest market in the world, followed by Canada. This escalation is developing the need to analyze, review and forecast the growth of the drug delivery devices market. Owing to the rapid evolution of the market in the use of injectable drug delivery technology, medical device companies that are able to launch new innovative equipment will be rewarded with huge benefits

Who should attend and Who You’ll Meet:

Directors/Senior Directors/Executive Directors and Vice Presidents/Senior Vice Presidents/Executive Vice Presidents and Heads/Leaders/Partners of

• CROs and CMOs

• Pharma Research Sites

• Pharma /Biotech and Medical Device industries

• Hospitals, Associations

Drug Delivery 2023 WCDFDD-2023, Novel Drug Delivery Congress, Medical Directors, Principal Investigators, Methodologists, and other Drug Formulation Experts, Drug Formulation Professors, Drug Formulation Graduates, Pharma Research professionals in Pharma Research Conferences along with Academicians: University Faculties like Directors, Senior Professors/Assistant Professors/ Associate Professors, Research Scholars, scientists who are related to drug formulation pharmaceutical research.

Target Audience:

• PhD Scholars in Drug Formulation
• PhD in Pharmaceutical Sciences
• Graduates and Post Graduates in Pharmaceutics
• Pharmaceutical Science Professors, Associate Professors, Assistant Professors
• Bio instruments Professionals
• Bio-informatics Professionals
• Directors, CEO’s of Organizations
• Supply Chain companies
• Pharmaceutical Manufacturing Companies
• Software development companies
• Drug Formulation Research Institutes and members

Participation Options & Benefits:

Participation Options: Drug delivery 2023 WCDFDD-2023, provides the participants with different modes or ways to participate such as Delegate or Speaker under Academic / Student / Business Category.

Keynote speaker: 45-50 minutes

Speaker (oral presentation): 25-30 minutes (only one person can present)

Speaker (workshop): 45-50 minutes (more than 1 can present)

Speaker (special session): 45-50 minutes (more than 1 can present)

Speaker (symposium): more than 45 minutes (more than 1 can present)

Delegate (only registration): will have access to all the sessions with all the benefits of registration

Poster presenter:  can present a poster and enjoy the benefits of delegate

Remote attendance:  can participate via video presentation or e-poster presentation

Exhibitor: can exhibit his/her company’s products by booking exhibitor booths of different sizes

Media partner

Sponsor

Collaborator